- Home
- Collections
- Congress 2024- Thursday
Congress 2024- Thursday
Collection Contents
21 - 40 of 48 results
-
-
How can we reduce the failure rate of diabetic management
BSAVA Congress Proceedings 2024Authors: Ellen Behrend, Ian Ramsey, Stijn Niessen and Anna Lena KramerHow can we reduce the failure rate of diabetic management
- Communication
- Drug delivery
- Practice support
- Effective monitoring
-
-
-
Lifelong care: patient and practice benefits of a patient-friendly approach
BSAVA Congress Proceedings 2024Authors: Jolle Kirpensteijn and Bryden StanleyA panel discussion on the patient and practice benefits of a patient-friendly approach to lifelong care.
-
-
-
Looking into the future of cardiology
BSAVA Congress Proceedings 2024Authors: Julia Sargent, Geoff Culshaw and Emily DuttonLooking into the future of cardiology
- Discuss future advances in medical treatment, cardiac imaging, biomarkers and the impact/role of AI in cardiology
-
-
-
MCTs: what are they and when can they be used in clinical practice?
BSAVA Congress Proceedings 2024Author Cecilla Villaverde HaroVetPlus will be running a session in the Exhibition Theatre where Cecilla Villaverde Haro will explain what MCTs are and when can they be used in clinical practice
-
-
-
Management of patients through the clinic
BSAVA Congress Proceedings 2024Authors: Tamsin Durston and Emma BrownBehavioural first aid
- Understand the concept of behavioural first aid
- Appreciate the most commonly presented behavioural issues and what questions to ask
- Appreciate the difference between training and behaviour: who and how to refer
Behavioural medication
- Understand the basic rational for use of behavioural mediciations
- Understand the relationship between medication and behaviour modification
- Understanding the importance of client comms - including the barriers to medication use
-
-
-
Medical treatment of heart disease
BSAVA Congress Proceedings 2024Authors: Geoff Culshaw and David ConnollyRAAS inhibition: whats the evidence in 2024?
- Understand the rationale of RAAS supression in heart disease
- Discuss the evidence for RAAS supression in asymptomatic (stage B) and symptomatic (stage C) heart disease
- Identify drugs for comprehensive RAAS supression
Advances in treatment of feline hypertrophic cardiomyopathy
- Identify current strategies in treating asymptomatic (stage B) and symptomatic (stage C) HCM
- Discuss treatment of obstructive form of HCM (SAM)
- Understand future options in the treatment of HCM
-
-
-
Mitral valve disease
BSAVA Congress Proceedings 2024Authors: Julia Sargent and Geoff CulshawEchocardiography in myxomatous mitral valve disease:how to define severity and prognosis
- Understand echocardiographic staging of MMVD
- Identify echocardiographic predictors of worse outcome
- Understand different strategies to quantify MMVD severity on echo
Atrial firbrillation in dogs: news from clinical research
- Understand different therapeutic strategies in atrial fibrillation: rhythm versus rate control
- Identify the first line anti-arrhythmic treatment for rate control in atrial fibrillation
- Understand treatment goals in atrial fibrillation and factors associated with worse outcome
-
-
-
Patient handling
BSAVA Congress Proceedings 2024Authors: Tamsin Durston and Emma BrownSpecies-specific responses to stress
- Understand dog specific responses to being in the clinic
- Understand cat specific responses to being in the clinic
- Understand how dogs and cats respond to lifting and examination
Approaches to handling
- Understand different approaches to handling dogs and cats
- Understand how owner presence may influence behaviour
- Consider how owners can prepare their pets for visiting the clinic
-
-
-
Practice and process design
BSAVA Congress Proceedings 2024Authors: Rachel Malkani and Sarah CollinsPractice and process design: dogs
- Understand the needs of dogs from the practice environment
- Identify realistic adaptations within the practice environment which impact on the wellbeing of dogs
- Understand the key client communication principles for embedding dog friendly principles
Practice and process design: cats
- Understand the needs of cats from the practice environment
- Identify realistic adaptations within the practice environment which impact on the wellbeing of cats
- Understand the key client communication principles for embedding cat friendly principles
- Understand different approaches to handling dogs and cats
- Understand how owner presence may influence behaviour
- Consider how owners can prepare their pets for visiting the clinic
-
-
-
Progressive care: Challenging the evidence: good science vs bad science
BSAVA Congress Proceedings 2024Authors: Martin Whitehead, Rachel Dean and Clare RusbridgeGood science vs bad science: what is the strength of the evidence out there? Can we rely on the evidence? Can it be misinterpreted and misused?
- Recognise the strengths and weaknesses of information presented to you (recognise sources of bias and confounding factors and how these may affect the interpretation of study results)
- Understand that research findings can be misinterpreted or misused which could harm you and your patients
- Identify misuse of evidence – identify instances where evidence may be misused or selectively used to support a particular agenda/ ethical implications of misusing evidence
-
-
-
Progressive care: mining the evidence
BSAVA Congress Proceedings 2024Author Clare RusbridgeMining the research: should this paper change what I do?
- Explain what differentiates good science from mediocre or bad science
- Decide when new information is relevant to your practice and when statistics matter
- Demonstrate how to progress care by using EBVM techniques in real life
Knowledge summaries: can they really change clinical practice?
- Explain how the strength of evidence affects the impact of a knowledge summary on current clinical practice
- Synthesise the information within a knowledge summary
- Synthesise whether the evidence suggests a change in current clinical practice
-
-
-
Progressive care: new data, new decisions
BSAVA Congress Proceedings 2024Authors: Rachel Dean and Karen HummClinical quality improvement: using YOUR data to change YOUR practice tomorrow
- Describe quality improvement activities in practice
- Plan your next practical QI project with your team
- Understand how to apply data to progress care
Clinical research: using it to improve clinical care
- Understand how to consider whether a paper is relevant to your practice
- Understand how to consider whether a paper is relevant to a particular patient
-
-
-
Progressive care: trusting the evidence
BSAVA Congress Proceedings 2024Author Martin WhiteheadAn introduction to agnotology
- Understand what agnotology is, and what disinformation and misinformation are within science and medicine
- Understand some of the methods used by vested interests to create and disseminate disinformation and misinformation within (veterinary) medical science
- Understand why disinformation and misinformation within science and medicine are often difficult to identify and counter.
-
-
-
Rabbits and exotics: friendly approaches
BSAVA Congress Proceedings 2024Authors: Richard Saunders and Adina ValentineRabbit friendly considerations
- Understand the concept of behavioural first aid
- Appreciate the most commonly presented behavioural issues and what questions to ask
Exotics friendly practice tips
- Appreciate the difference between training and behaviour: who and how to refer
- Understand the basic rational for use of behavioural mediciations
- Understand the relationship between medication and behaviour modification
- Understanding the importance of client comms - including the barriers to medication use
-
-
-
SGLT2 inhibitors in feline diabetes 1
BSAVA Congress Proceedings 2024Author Ellen BehrendAn introduction to SGLT2 inhibitors and the USA experience
- Know the mechanism of action of SGLT-2 inhibitors and be able to compare with other oral hypoglycaemics and insulin
- Understand why SGLT2 inhibitors work well in many cases of feline (but not canine) diabetes. Understand which cases of feline diabetes mellitus are not suitable for SGLT-2 inhibitors
- Be aware of the evidence supporting the use of SGLT-2 inhibitors in several USA studies
-
-
-
SGLT2 inhibitors in feline diabetes 2
BSAVA Congress Proceedings 2024Authors: Anna Lena Kramer and Stijn NiessenHow and when I use SGLT2 inhibitors
- Be aware of the evidence supporting the use of SGLT-2 inhibitors in Europe
- Know the specific formulations of SGLT-2 inhibitors available to UK vets
Velagliflozin: the European experience
- Be aware of the evidence supporting the use of SGLT-2 inhibitors in Europe
- Know the specific formulations of SGLT-2 inhibitors available to UK vets
-
-
-
SGLT2 inhibitors in feline diabetes 3
BSAVA Congress Proceedings 2024Authors: Ellen Behrend, Anna Lena Kramer, Stijn Niessen and Ian RamseyHow and when I use SGLT-2 inhibitors
- Understand the particular problems of SGLT-2 inhibitors, specifically the recognition of euglycaemic ketoacidosis and its subsequent treatment
- Know how to start SGLT-2 inhibitors and how to monitor their effect in diabetic cats
-
-
-
Safety culture in veterinary practice
BSAVA Congress Proceedings 2024Authors: Olivia Oginska, Helen Silver MacMahon and Alan RobinsonIntroduction to safety culture
- Consider what safety culture is
- Understand why safety culture is fundamental to veterinary practice
- Define how to implement a safety culture
Psychological safety as a pillar of culture
- Understand what psychological safety is
- Consider how we can build psychological safety as individuals and teams
- Identify what psychological safety is not
-
-
-
Should I keep pressure-lowering drops in the pharmacy?
BSAVA Congress Proceedings 2024Authors: Richard Everson and Lorraine FlemingThis session in the Exhibition Theatre with Richard Everson and Lorraine Fleming covers pressure lowering treatments
-
-
-
Steriods and non-steroidals in ophthalmology cases
BSAVA Congress Proceedings 2024Authors: Richard Everson and Lorraine FlemingThis session in the Exhibition Theatre with Richard Everson and Lorraine Fleming covers steriods and non-steroidals in ophthalmology cases
-